OmniAb (OABI) Other Operating Expenses (2021 - 2026)
OmniAb's (OABI) quarterly Other Operating Expenses came in at $46000.0 in Q1 2026, down 93.87% year-on-year from $750000.0 in Q1 2025, and up 129.3% on a QoQ basis from -$157000.0 in Q4 2025.
OmniAb (OABI) Other Operating Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Other Operating Expenses data on file, last reported at $46000.0 in Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 93.87% year-over-year to $46000.0 in Q1 2026; TTM through Mar 2026 was $1.8 million, a 41.78% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, up 7.78% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $46000.0, up from -$157000.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for OABI reached as high as $2.5 million in Q2 2024 and fell as low as -$165000.0 in Q2 2022.
- Historically, Other Operating Expenses has averaged $315352.9 across 5 years, with a median of $34000.0 in 2025.
- Across the five-year window, Other Operating Expenses slumped 7651.49% in 2022 and soared 1902.86% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at $106000.0 in 2022, then sank by 86.79% to $14000.0 in 2023, then soared by 192.86% to $41000.0 in 2024, then slumped by 482.93% to -$157000.0 in 2025, then soared by 129.3% to $46000.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $46000.0 in Q1 2026, -$157000.0 in Q4 2025, and $34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -54,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -140,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | -165,000.00 |
| Mar 31, 2022 | 443,000.00 |
| Dec 31, 2021 | 70.18 Mn |
| Sep 30, 2021 | 170,579.00 |
| Jun 30, 2021 | 2,185.00 |